Characteristics of patients before HCT
Characteristic . | Data (N = 129) . |
---|---|
Year of HCT | |
2005-2010 | 79 (61) |
2011-2015 | 50 (39) |
Age at HCT, y | |
<1 | 53 (41) |
1-1.99 | 40 (31) |
2-4.99 | 24 (19) |
≥5 | 12 (9) |
Lansky/Karnofsky | |
Median (range) | 100 (60-100) |
Family history of WAS | |
Yes | 48 (37) |
No | 69 (54) |
Unknown | 12 (9) |
History of eczema before HCT | |
Yes | 111 (86) |
No | 15 (12) |
Unknown | 3 (2) |
History of chronic thrombocytopenia before HCT* | |
Yes | 109 (85) |
No | 13 (10) |
Unknown | 7 (5) |
History of splenectomy before HCT | |
Yes | 8 (6) |
No | 121 (94) |
WAS mutations identified | |
Nonsense | 30 (23) |
Frameshift | 34 (26) |
Deletion | 21 (16) |
Insertion | 12 (9) |
Deletion/insertion | 1 (1) |
Missense | 30 (23) |
Splice site | 20 (15) |
Invariant | 13 (10) |
Variant | 7 (5) |
In-frame insertion | 2 (2) |
Large deletion | 5 (4) |
Unknown | 8 (6) |
WASP expression by flow cytometry or predicted | |
Absent | 83 (64) |
Reduced | 42 (33) |
Normal | 2 (1.5) |
Unknown | 2 (1.5) |
History of recurrent or severe infections before HCT | |
Yes | 64 (50) |
No | 65 (50) |
History of autoimmune disease before HCT/present at time of conditioning | |
Yes | 32 (25)/26 (20) |
Thrombocytopenia | 19 (15)/17 (13) |
Hemolytic anemia | 10 (8)/6 (5) |
Neutropenia | 7 (5)/5 (4) |
Vasculitis | 3 (2)/1 (1) |
Inflammatory bowel disease | 2 (2)/2 (2) |
Arthritis | 1 (1)/1 (1) |
Nephritis | 1 (1)/1 (1) |
Alopecia | 1 (1)/1 (1) |
No | 91 (70) |
Unknown | 6 (5) |
Characteristic . | Data (N = 129) . |
---|---|
Year of HCT | |
2005-2010 | 79 (61) |
2011-2015 | 50 (39) |
Age at HCT, y | |
<1 | 53 (41) |
1-1.99 | 40 (31) |
2-4.99 | 24 (19) |
≥5 | 12 (9) |
Lansky/Karnofsky | |
Median (range) | 100 (60-100) |
Family history of WAS | |
Yes | 48 (37) |
No | 69 (54) |
Unknown | 12 (9) |
History of eczema before HCT | |
Yes | 111 (86) |
No | 15 (12) |
Unknown | 3 (2) |
History of chronic thrombocytopenia before HCT* | |
Yes | 109 (85) |
No | 13 (10) |
Unknown | 7 (5) |
History of splenectomy before HCT | |
Yes | 8 (6) |
No | 121 (94) |
WAS mutations identified | |
Nonsense | 30 (23) |
Frameshift | 34 (26) |
Deletion | 21 (16) |
Insertion | 12 (9) |
Deletion/insertion | 1 (1) |
Missense | 30 (23) |
Splice site | 20 (15) |
Invariant | 13 (10) |
Variant | 7 (5) |
In-frame insertion | 2 (2) |
Large deletion | 5 (4) |
Unknown | 8 (6) |
WASP expression by flow cytometry or predicted | |
Absent | 83 (64) |
Reduced | 42 (33) |
Normal | 2 (1.5) |
Unknown | 2 (1.5) |
History of recurrent or severe infections before HCT | |
Yes | 64 (50) |
No | 65 (50) |
History of autoimmune disease before HCT/present at time of conditioning | |
Yes | 32 (25)/26 (20) |
Thrombocytopenia | 19 (15)/17 (13) |
Hemolytic anemia | 10 (8)/6 (5) |
Neutropenia | 7 (5)/5 (4) |
Vasculitis | 3 (2)/1 (1) |
Inflammatory bowel disease | 2 (2)/2 (2) |
Arthritis | 1 (1)/1 (1) |
Nephritis | 1 (1)/1 (1) |
Alopecia | 1 (1)/1 (1) |
No | 91 (70) |
Unknown | 6 (5) |
Unless otherwise specified, data are the number of recipients (percentage of total study group).
Chronic thrombocytopenia is defined as a platelet count <100 000/μL on 2 evaluations separated by at least 3 months.